2024 Q2 Form 10-K Financial Statement
#000155837024005211 Filed on April 16, 2024
Income Statement
Concept | 2024 Q2 | 2023 Q4 | 2023 |
---|---|---|---|
Revenue | $9.282M | $7.403M | $30.11M |
YoY Change | 13.54% | -2.08% | -46.18% |
Cost Of Revenue | $6.203M | $6.525M | $26.43M |
YoY Change | -11.2% | -8.74% | -39.79% |
Gross Profit | $3.079M | $878.0K | $3.681M |
YoY Change | 158.74% | 114.15% | -69.45% |
Gross Profit Margin | 33.17% | 11.86% | 12.23% |
Selling, General & Admin | $3.072M | $20.91M | $12.96M |
YoY Change | -39.76% | 199.58% | -58.43% |
% of Gross Profit | 99.77% | 2381.66% | 352.0% |
Research & Development | |||
YoY Change | |||
% of Gross Profit | |||
Depreciation & Amortization | $228.0K | $295.0K | $2.065M |
YoY Change | -61.55% | -73.18% | -61.96% |
% of Gross Profit | 7.41% | 33.6% | 56.1% |
Operating Expenses | $3.072M | $5.501M | $12.96M |
YoY Change | -47.84% | -31.83% | -58.43% |
Operating Profit | -$1.893M | -$4.623M | -$28.21M |
YoY Change | -59.93% | -39.65% | -9.49% |
Interest Expense | $174.0K | $274.0K | $568.0K |
YoY Change | -119.55% | 95.71% | -346.96% |
% of Operating Profit | |||
Other Income/Expense, Net | -$72.00K | -$64.00K | -$410.0K |
YoY Change | -40.0% | -93.96% | -63.75% |
Pretax Income | -$1.791M | -$6.508M | -$27.99M |
YoY Change | -68.46% | -54.2% | -14.06% |
Income Tax | $35.00K | $35.00K | |
% Of Pretax Income | |||
Net Earnings | -$1.996M | -$6.584M | -$27.74M |
YoY Change | -65.17% | -51.08% | -15.52% |
Net Earnings / Revenue | -21.5% | -88.94% | -92.14% |
Basic Earnings Per Share | -$0.48 | -$6.64 | |
Diluted Earnings Per Share | -$0.48 | -$1.57 | -$6.64 |
COMMON SHARES | |||
Basic Shares Outstanding | 4.183M | 4.180M | 4.175M |
Diluted Shares Outstanding | 4.183M | 4.175M |
Balance Sheet
Concept | 2024 Q2 | 2023 Q4 | 2023 |
---|---|---|---|
SHORT-TERM ASSETS | |||
Cash & Short-Term Investments | $18.38M | $23.05M | $23.05M |
YoY Change | -42.37% | -45.38% | -45.38% |
Cash & Equivalents | $5.418M | $8.437M | $316.0K |
Short-Term Investments | $12.97M | $14.61M | $14.61M |
Other Short-Term Assets | $1.501M | $949.0K | $949.0K |
YoY Change | 3.88% | -15.42% | -13.73% |
Inventory | $871.0K | $900.0K | $900.0K |
Prepaid Expenses | $1.421M | $894.0K | |
Receivables | $2.380M | $1.667M | $1.667M |
Other Receivables | $0.00 | $0.00 | $0.00 |
Total Short-Term Assets | $23.14M | $26.57M | $26.57M |
YoY Change | -35.96% | -43.87% | -43.84% |
LONG-TERM ASSETS | |||
Property, Plant & Equipment | $2.454M | $2.454M | $7.110M |
YoY Change | -36.54% | -33.06% | -40.25% |
Goodwill | $1.389M | $1.371M | |
YoY Change | -65.48% | -65.93% | |
Intangibles | $1.187M | $1.353M | |
YoY Change | -68.01% | -66.24% | |
Long-Term Investments | $50.00K | ||
YoY Change | |||
Other Assets | $1.756M | $1.842M | $2.543M |
YoY Change | 2.39% | -22.25% | -17.97% |
Total Long-Term Assets | $13.16M | $12.43M | $12.43M |
YoY Change | -35.7% | -46.19% | -46.2% |
TOTAL ASSETS | |||
Total Short-Term Assets | $23.14M | $26.57M | $26.57M |
Total Long-Term Assets | $13.16M | $12.43M | $12.43M |
Total Assets | $36.29M | $38.99M | $38.99M |
YoY Change | -35.87% | -44.63% | -44.61% |
SHORT-TERM LIABILITIES | |||
YoY Change | |||
Accounts Payable | $2.780M | $1.099M | $1.099M |
YoY Change | 28.47% | -52.47% | -86.26% |
Accrued Expenses | $6.735M | $7.370M | $7.370M |
YoY Change | 6.9% | 183.46% | 183.46% |
Deferred Revenue | |||
YoY Change | |||
Short-Term Debt | $0.00 | $0.00 | $0.00 |
YoY Change | |||
Long-Term Debt Due | |||
YoY Change | |||
Total Short-Term Liabilities | $10.44M | $9.330M | $9.330M |
YoY Change | 12.67% | -14.84% | -15.18% |
LONG-TERM LIABILITIES | |||
Long-Term Debt | $0.00 | $0.00 | $0.00 |
YoY Change | |||
Other Long-Term Liabilities | $8.622M | $8.692M | $8.692M |
YoY Change | -16.29% | -24.42% | -24.42% |
Total Long-Term Liabilities | $8.622M | $8.692M | $8.692M |
YoY Change | -16.29% | -24.42% | -24.42% |
TOTAL LIABILITIES | |||
Total Short-Term Liabilities | $10.44M | $9.330M | $9.330M |
Total Long-Term Liabilities | $8.622M | $8.692M | $8.692M |
Total Liabilities | $19.06M | $18.02M | $25.99M |
YoY Change | -2.68% | -19.82% | -14.78% |
SHAREHOLDERS EQUITY | |||
Retained Earnings | -$460.4M | -$455.9M | |
YoY Change | 4.78% | 6.48% | |
Common Stock | $42.00K | $42.00K | |
YoY Change | -94.96% | -94.95% | |
Preferred Stock | |||
YoY Change | |||
Treasury Stock (at cost) | |||
YoY Change | |||
Treasury Stock Shares | |||
Shareholders Equity | $8.798M | $13.00M | $13.00M |
YoY Change | |||
Total Liabilities & Shareholders Equity | $36.29M | $38.99M | $38.99M |
YoY Change | -35.87% | -44.63% | -44.61% |
Cashflow Statement
Concept | 2024 Q2 | 2023 Q4 | 2023 |
---|---|---|---|
OPERATING ACTIVITIES | |||
Net Income | -$1.996M | -$6.584M | -$27.74M |
YoY Change | -65.17% | -51.08% | -15.52% |
Depreciation, Depletion And Amortization | $228.0K | $295.0K | $2.065M |
YoY Change | -61.55% | -73.18% | -61.96% |
Cash From Operating Activities | -$443.0K | -$3.201M | -$16.07M |
YoY Change | -83.89% | -52.79% | -33.55% |
INVESTING ACTIVITIES | |||
Capital Expenditures | $362.0K | $266.0K | $1.905M |
YoY Change | 20.67% | -65.0% | -70.53% |
Acquisitions | |||
YoY Change | |||
Other Investing Activities | $1.914M | $7.088M | $8.023M |
YoY Change | -1163.33% | -130.62% | -134.66% |
Cash From Investing Activities | $1.552M | $6.822M | $5.650M |
YoY Change | -423.33% | -128.53% | -116.22% |
FINANCING ACTIVITIES | |||
Cash Dividend Paid | |||
YoY Change | |||
Common Stock Issuance & Retirement, Net | |||
YoY Change | |||
Debt Paid & Issued, Net | |||
YoY Change | |||
Cash From Financing Activities | 4.000K | 0.000 | 8.000K |
YoY Change | -103.33% | -100.0% | -100.03% |
NET CHANGE | |||
Cash From Operating Activities | -443.0K | -3.201M | -16.07M |
Cash From Investing Activities | 1.552M | 6.822M | 5.650M |
Cash From Financing Activities | 4.000K | 0.000 | 8.000K |
Net Change In Cash | 1.113M | 3.621M | -10.60M |
YoY Change | -133.22% | -111.91% | -87.74% |
FREE CASH FLOW | |||
Cash From Operating Activities | -$443.0K | -$3.201M | -$16.07M |
Capital Expenditures | $362.0K | $266.0K | $1.905M |
Free Cash Flow | -$805.0K | -$3.467M | -$17.98M |
YoY Change | -73.61% | -54.02% | -41.34% |
Facts In Submission
Frame | Concept Type | Concept / XBRL Key | Value | Unit |
---|---|---|---|---|
CY2023Q4 | us-gaap |
Commitments And Contingencies
CommitmentsAndContingencies
|
||
CY2022Q4 | us-gaap |
Commitments And Contingencies
CommitmentsAndContingencies
|
||
CY2023 | us-gaap |
Earnings Per Share Diluted
EarningsPerShareDiluted
|
-6.64 | |
CY2022 | us-gaap |
Earnings Per Share Diluted
EarningsPerShareDiluted
|
-7.01 | |
CY2023 | dei |
Entity Central Index Key
EntityCentralIndexKey
|
0001410428 | |
CY2023 | dei |
Current Fiscal Year End Date
CurrentFiscalYearEndDate
|
--12-31 | |
CY2023 | dei |
Document Fiscal Year Focus
DocumentFiscalYearFocus
|
2023 | |
CY2023 | dei |
Document Fiscal Period Focus
DocumentFiscalPeriodFocus
|
FY | |
CY2023 | dei |
Amendment Flag
AmendmentFlag
|
false | |
CY2023 | dei |
Amendment Flag
AmendmentFlag
|
false | |
CY2022Q4 | us-gaap |
Common Stock Shares Issued
CommonStockSharesIssued
|
4161613 | |
CY2023Q4 | us-gaap |
Common Stock Shares Outstanding
CommonStockSharesOutstanding
|
4179631 | |
CY2023Q3 | us-gaap |
Stockholders Equity Note Stock Split Conversion Ratio1
StockholdersEquityNoteStockSplitConversionRatio1
|
0.05 | |
CY2023Q3 | us-gaap |
Stockholders Equity Note Stock Split Conversion Ratio1
StockholdersEquityNoteStockSplitConversionRatio1
|
0.05 | |
CY2023Q3 | us-gaap |
Stockholders Equity Note Stock Split Conversion Ratio1
StockholdersEquityNoteStockSplitConversionRatio1
|
0.05 | |
CY2023Q3 | us-gaap |
Stockholders Equity Note Stock Split Conversion Ratio1
StockholdersEquityNoteStockSplitConversionRatio1
|
0.05 | |
CY2023Q3 | us-gaap |
Stockholders Equity Note Stock Split Conversion Ratio1
StockholdersEquityNoteStockSplitConversionRatio1
|
0.05 | |
CY2023Q3 | us-gaap |
Stockholders Equity Note Stock Split Conversion Ratio1
StockholdersEquityNoteStockSplitConversionRatio1
|
0.05 | |
CY2022 | us-gaap |
Impairment Of Intangible Asset Finite Lived Statement Of Income Or Comprehensive Income Extensible Enumeration
ImpairmentOfIntangibleAssetFiniteLivedStatementOfIncomeOrComprehensiveIncomeExtensibleEnumeration
|
http://fasb.org/us-gaap/2023#ImpairmentOfLongLivedAssetsHeldForUse | |
CY2023 | us-gaap |
Impairment Of Intangible Asset Finite Lived Statement Of Income Or Comprehensive Income Extensible Enumeration
ImpairmentOfIntangibleAssetFiniteLivedStatementOfIncomeOrComprehensiveIncomeExtensibleEnumeration
|
http://fasb.org/us-gaap/2023#ImpairmentOfLongLivedAssetsHeldForUse | |
CY2023Q3 | us-gaap |
Earnings Per Share Diluted
EarningsPerShareDiluted
|
-2.76 | |
us-gaap |
Earnings Per Share Diluted
EarningsPerShareDiluted
|
-5.46 | ||
CY2022Q4 | us-gaap |
Common Stock Shares Issued
CommonStockSharesIssued
|
4161613 | |
CY2023Q3 | us-gaap |
Common Stock Shares Outstanding
CommonStockSharesOutstanding
|
4174381 | |
CY2023Q3 | us-gaap |
Stockholders Equity Note Stock Split Conversion Ratio1
StockholdersEquityNoteStockSplitConversionRatio1
|
0.05 | |
CY2023Q3 | us-gaap |
Stockholders Equity Note Stock Split Conversion Ratio1
StockholdersEquityNoteStockSplitConversionRatio1
|
0.05 | |
CY2023 | dei |
Document Type
DocumentType
|
10-K | |
CY2023 | dei |
Document Annual Report
DocumentAnnualReport
|
true | |
CY2023 | dei |
Document Period End Date
DocumentPeriodEndDate
|
2023-12-31 | |
CY2023 | dei |
Document Transition Report
DocumentTransitionReport
|
false | |
CY2023 | dei |
Entity File Number
EntityFileNumber
|
001-34785 | |
CY2023 | dei |
Entity Registrant Name
EntityRegistrantName
|
XWELL, Inc. | |
CY2023 | dei |
Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
|
DE | |
CY2023 | dei |
Entity Tax Identification Number
EntityTaxIdentificationNumber
|
20-4988129 | |
CY2023 | dei |
Entity Address Address Line1
EntityAddressAddressLine1
|
254 West 31st Street | |
CY2023 | dei |
Entity Address Address Line2
EntityAddressAddressLine2
|
11th Floor | |
CY2023 | dei |
Entity Address City Or Town
EntityAddressCityOrTown
|
New York | |
CY2023 | dei |
Entity Address State Or Province
EntityAddressStateOrProvince
|
NY | |
CY2023Q4 | us-gaap |
Other Assets Noncurrent
OtherAssetsNoncurrent
|
1842000 | |
CY2022Q4 | us-gaap |
Other Assets Noncurrent
OtherAssetsNoncurrent
|
2369000 | |
CY2023Q4 | us-gaap |
Assets
Assets
|
38993000 | |
CY2022Q4 | us-gaap |
Assets
Assets
|
70426000 | |
CY2023Q4 | us-gaap |
Accounts Payable Current
AccountsPayableCurrent
|
1099000 | |
CY2023 | dei |
Entity Address Postal Zip Code
EntityAddressPostalZipCode
|
10001 | |
CY2023 | dei |
City Area Code
CityAreaCode
|
212 | |
CY2023 | dei |
Local Phone Number
LocalPhoneNumber
|
750-9595 | |
CY2023 | dei |
Security12b Title
Security12bTitle
|
Common Stock, par value $0.01 per share | |
CY2023 | dei |
Trading Symbol
TradingSymbol
|
XWEL | |
CY2023 | dei |
Security Exchange Name
SecurityExchangeName
|
NASDAQ | |
CY2023 | dei |
Entity Well Known Seasoned Issuer
EntityWellKnownSeasonedIssuer
|
No | |
CY2023 | dei |
Entity Voluntary Filers
EntityVoluntaryFilers
|
No | |
CY2023 | dei |
Entity Current Reporting Status
EntityCurrentReportingStatus
|
Yes | |
CY2023 | dei |
Entity Interactive Data Current
EntityInteractiveDataCurrent
|
Yes | |
CY2023 | dei |
Entity Filer Category
EntityFilerCategory
|
Non-accelerated Filer | |
CY2023 | dei |
Entity Small Business
EntitySmallBusiness
|
true | |
CY2023 | dei |
Entity Emerging Growth Company
EntityEmergingGrowthCompany
|
false | |
CY2023 | dei |
Icfr Auditor Attestation Flag
IcfrAuditorAttestationFlag
|
false | |
CY2023 | dei |
Document Fin Stmt Error Correction Flag
DocumentFinStmtErrorCorrectionFlag
|
true | |
CY2023 | dei |
Document Fin Stmt Restatement Recovery Analysis Flag
DocumentFinStmtRestatementRecoveryAnalysisFlag
|
false | |
CY2023 | dei |
Entity Shell Company
EntityShellCompany
|
false | |
CY2023Q2 | dei |
Entity Public Float
EntityPublicFloat
|
16663729 | |
CY2024Q2 | dei |
Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
|
4183435 | |
CY2023Q4 | ecd |
Rule10b51 Arr Adopted Flag
Rule10b51ArrAdoptedFlag
|
false | |
CY2023Q4 | ecd |
Non Rule10b51 Arr Adopted Flag
NonRule10b51ArrAdoptedFlag
|
false | |
CY2023Q4 | ecd |
Rule10b51 Arr Trmntd Flag
Rule10b51ArrTrmntdFlag
|
false | |
CY2023Q4 | ecd |
Non Rule10b51 Arr Trmntd Flag
NonRule10b51ArrTrmntdFlag
|
false | |
CY2023 | dei |
Auditor Firm
AuditorFirmId
|
688 | |
CY2023 | dei |
Auditor Name
AuditorName
|
Marcum LLP | |
CY2023 | dei |
Auditor Location
AuditorLocation
|
East Hanover, New Jersey | |
CY2023Q4 | us-gaap |
Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
|
8437000 | |
CY2022Q4 | us-gaap |
Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
|
19038000 | |
CY2023Q4 | us-gaap |
Marketable Securities Current
MarketableSecuritiesCurrent
|
14613000 | |
CY2022Q4 | us-gaap |
Marketable Securities Current
MarketableSecuritiesCurrent
|
23153000 | |
CY2023Q4 | us-gaap |
Accounts Receivable Net Current
AccountsReceivableNetCurrent
|
1667000 | |
CY2022Q4 | us-gaap |
Accounts Receivable Net Current
AccountsReceivableNetCurrent
|
2858000 | |
CY2023Q4 | us-gaap |
Inventory Net
InventoryNet
|
900000 | |
CY2022Q4 | us-gaap |
Inventory Net
InventoryNet
|
1161000 | |
CY2023Q4 | us-gaap |
Other Assets Current
OtherAssetsCurrent
|
949000 | |
CY2022Q4 | us-gaap |
Other Assets Current
OtherAssetsCurrent
|
1122000 | |
CY2023Q4 | us-gaap |
Assets Current
AssetsCurrent
|
26566000 | |
CY2022Q4 | us-gaap |
Assets Current
AssetsCurrent
|
47332000 | |
CY2023Q4 | us-gaap |
Restricted Cash And Cash Equivalents Noncurrent
RestrictedCashAndCashEquivalentsNoncurrent
|
751000 | |
CY2022Q4 | us-gaap |
Restricted Cash And Cash Equivalents Noncurrent
RestrictedCashAndCashEquivalentsNoncurrent
|
751000 | |
CY2023Q4 | us-gaap |
Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
|
2454000 | |
CY2022Q4 | us-gaap |
Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
|
3666000 | |
CY2023Q4 | us-gaap |
Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
|
1353000 | |
CY2022Q4 | us-gaap |
Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
|
4008000 | |
CY2023Q4 | us-gaap |
Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
|
4656000 | |
CY2022Q4 | us-gaap |
Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
|
8276000 | |
CY2023Q4 | us-gaap |
Goodwill
Goodwill
|
1371000 | |
CY2022Q4 | us-gaap |
Goodwill
Goodwill
|
4024000 | |
CY2022Q4 | us-gaap |
Accounts Payable Current
AccountsPayableCurrent
|
2312000 | |
CY2023Q4 | us-gaap |
Accrued Liabilities And Other Liabilities
AccruedLiabilitiesAndOtherLiabilities
|
4968000 | |
CY2022Q4 | us-gaap |
Accrued Liabilities And Other Liabilities
AccruedLiabilitiesAndOtherLiabilities
|
5719000 | |
CY2023Q4 | us-gaap |
Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
|
2402000 | |
CY2022Q4 | us-gaap |
Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
|
2586000 | |
CY2023Q4 | us-gaap |
Deferred Revenue
DeferredRevenue
|
861000 | |
CY2022Q4 | us-gaap |
Deferred Revenue
DeferredRevenue
|
339000 | |
CY2023Q4 | us-gaap |
Liabilities Current
LiabilitiesCurrent
|
9330000 | |
CY2022Q4 | us-gaap |
Liabilities Current
LiabilitiesCurrent
|
10956000 | |
CY2023Q4 | us-gaap |
Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
|
8692000 | |
CY2022Q4 | us-gaap |
Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
|
11521000 | |
CY2023Q4 | us-gaap |
Liabilities
Liabilities
|
18022000 | |
CY2022Q4 | us-gaap |
Liabilities
Liabilities
|
22477000 | |
CY2022Q4 | us-gaap |
Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
|
0.01 | |
CY2023Q4 | us-gaap |
Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
|
0.01 | |
CY2022Q4 | us-gaap |
Common Stock Shares Authorized
CommonStockSharesAuthorized
|
150000000 | |
CY2023Q4 | us-gaap |
Common Stock Shares Authorized
CommonStockSharesAuthorized
|
150000000 | |
CY2023Q4 | us-gaap |
Common Stock Shares Issued
CommonStockSharesIssued
|
4179631 | |
CY2022Q4 | us-gaap |
Common Stock Shares Outstanding
CommonStockSharesOutstanding
|
4161613 | |
CY2023Q4 | us-gaap |
Common Stock Value
CommonStockValue
|
42000 | |
CY2022Q4 | us-gaap |
Common Stock Value
CommonStockValue
|
42000 | |
CY2023Q4 | us-gaap |
Additional Paid In Capital
AdditionalPaidInCapital
|
470737000 | |
CY2022Q4 | us-gaap |
Additional Paid In Capital
AdditionalPaidInCapital
|
468530000 | |
CY2023Q4 | us-gaap |
Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
|
-455853000 | |
CY2022Q4 | us-gaap |
Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
|
-428112000 | |
CY2023Q4 | us-gaap |
Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
|
-1924000 | |
CY2022Q4 | us-gaap |
Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
|
-534000 | |
CY2023Q4 | us-gaap |
Stockholders Equity
StockholdersEquity
|
13002000 | |
CY2022Q4 | us-gaap |
Stockholders Equity
StockholdersEquity
|
39926000 | |
CY2023Q4 | us-gaap |
Minority Interest
MinorityInterest
|
7969000 | |
CY2022Q4 | us-gaap |
Minority Interest
MinorityInterest
|
8023000 | |
CY2023Q4 | us-gaap |
Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
|
20971000 | |
CY2022Q4 | us-gaap |
Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
|
47949000 | |
CY2023Q4 | us-gaap |
Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
|
38993000 | |
CY2022Q4 | us-gaap |
Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
|
70426000 | |
CY2023 | us-gaap |
Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
|
30109000 | |
CY2022 | us-gaap |
Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
|
55939000 | |
CY2023 | us-gaap |
Cost Direct Labor
CostDirectLabor
|
17932000 | |
CY2022 | us-gaap |
Cost Direct Labor
CostDirectLabor
|
21437000 | |
CY2023 | xwel |
Cost Of Occupancy
CostOfOccupancy
|
4473000 | |
CY2022 | xwel |
Cost Of Occupancy
CostOfOccupancy
|
4138000 | |
CY2023 | xwel |
Products And Other Operating Costs
ProductsAndOtherOperatingCosts
|
4023000 | |
CY2022 | xwel |
Products And Other Operating Costs
ProductsAndOtherOperatingCosts
|
18316000 | |
CY2023 | us-gaap |
Cost Of Revenue
CostOfRevenue
|
26428000 | |
CY2022 | us-gaap |
Cost Of Revenue
CostOfRevenue
|
43891000 | |
CY2023 | us-gaap |
Gross Profit
GrossProfit
|
3681000 | |
CY2022 | us-gaap |
Gross Profit
GrossProfit
|
12048000 | |
CY2023 | us-gaap |
Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
|
2065000 | |
CY2022 | us-gaap |
Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
|
5429000 | |
CY2023 | us-gaap |
Impairment Of Long Lived Assets Held For Use
ImpairmentOfLongLivedAssetsHeldForUse
|
3927000 | |
CY2022 | us-gaap |
Impairment Of Long Lived Assets Held For Use
ImpairmentOfLongLivedAssetsHeldForUse
|
4669000 | |
CY2023 | us-gaap |
Goodwill Impairment Loss
GoodwillImpairmentLoss
|
4024000 | |
CY2023 | us-gaap |
Gain Loss On Disposition Of Assets1
GainLossOnDispositionOfAssets1
|
-34000 | |
CY2022 | us-gaap |
Gain Loss On Disposition Of Assets1
GainLossOnDispositionOfAssets1
|
-834000 | |
CY2023 | us-gaap |
Operating Lease Impairment Loss
OperatingLeaseImpairmentLoss
|
926000 | |
CY2022 | us-gaap |
Operating Lease Impairment Loss
OperatingLeaseImpairmentLoss
|
1110000 | |
CY2023 | us-gaap |
Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
|
12957000 | |
CY2022 | us-gaap |
Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
|
21178000 | |
CY2023 | us-gaap |
Salaries Wages And Officers Compensation
SalariesWagesAndOfficersCompensation
|
7954000 | |
CY2022 | us-gaap |
Salaries Wages And Officers Compensation
SalariesWagesAndOfficersCompensation
|
9991000 | |
CY2023 | us-gaap |
Costs And Expenses
CostsAndExpenses
|
31887000 | |
CY2022 | us-gaap |
Costs And Expenses
CostsAndExpenses
|
43211000 | |
CY2023 | us-gaap |
Operating Income Loss
OperatingIncomeLoss
|
-28206000 | |
CY2022 | us-gaap |
Operating Income Loss
OperatingIncomeLoss
|
-31163000 | |
CY2023 | us-gaap |
Interest Income Expense Net
InterestIncomeExpenseNet
|
448000 | |
CY2022 | us-gaap |
Interest Income Expense Net
InterestIncomeExpenseNet
|
384000 | |
CY2023 | us-gaap |
Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
|
-738000 | |
CY2022 | us-gaap |
Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
|
-664000 | |
CY2023 | us-gaap |
Debt And Equity Securities Realized Gain Loss
DebtAndEquitySecuritiesRealizedGainLoss
|
912000 | |
CY2023 | us-gaap |
Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
|
-410000 | |
CY2022 | us-gaap |
Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
|
-1131000 | |
CY2023 | us-gaap |
Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
|
-27994000 | |
CY2022 | us-gaap |
Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
|
-32574000 | |
CY2023 | us-gaap |
Income Tax Expense Benefit
IncomeTaxExpenseBenefit
|
35000 | |
CY2022 | us-gaap |
Income Tax Expense Benefit
IncomeTaxExpenseBenefit
|
55000 | |
CY2023 | us-gaap |
Profit Loss
ProfitLoss
|
-28029000 | |
CY2022 | us-gaap |
Profit Loss
ProfitLoss
|
-32629000 | |
CY2023 | us-gaap |
Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
|
-288000 | |
CY2022 | us-gaap |
Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
|
208000 | |
CY2023 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-27741000 | |
CY2022 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-32837000 | |
CY2023 | us-gaap |
Profit Loss
ProfitLoss
|
-28029000 | |
CY2022 | us-gaap |
Profit Loss
ProfitLoss
|
-32629000 | |
CY2023 | us-gaap |
Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
|
-1390000 | |
CY2022 | us-gaap |
Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
|
-222000 | |
CY2023 | us-gaap |
Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
|
-29419000 | |
CY2022 | us-gaap |
Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
|
-32851000 | |
CY2023 | us-gaap |
Earnings Per Share Basic
EarningsPerShareBasic
|
-6.64 | |
CY2022 | us-gaap |
Earnings Per Share Basic
EarningsPerShareBasic
|
-7.01 | |
CY2023 | us-gaap |
Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
|
4175220 | |
CY2022 | us-gaap |
Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
|
4682767 | |
CY2023 | us-gaap |
Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
|
4175220 | |
CY2022 | us-gaap |
Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
|
4682767 | |
CY2021Q4 | us-gaap |
Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
|
99935000 | |
CY2022 | us-gaap |
Stock Issued During Period Value Acquisitions
StockIssuedDuringPeriodValueAcquisitions
|
906000 | |
CY2022 | us-gaap |
Adjustments Related To Tax Withholding For Share Based Compensation
AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
|
73000 | |
CY2022 | us-gaap |
Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
|
3770000 | |
CY2022 | us-gaap |
Profit Loss
ProfitLoss
|
-32629000 | |
CY2022 | us-gaap |
Stock Repurchased And Retired During Period Value
StockRepurchasedAndRetiredDuringPeriodValue
|
23789000 | |
CY2022 | us-gaap |
Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
|
-343000 | |
CY2022 | us-gaap |
Minority Interest Decrease From Distributions To Noncontrolling Interest Holders
MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders
|
956000 | |
CY2022 | us-gaap |
Noncontrolling Interest Increase From Subsidiary Equity Issuance
NoncontrollingInterestIncreaseFromSubsidiaryEquityIssuance
|
1025000 | |
CY2022 | xwel |
Adjustments To Additional Paid In Capital Grant Of Stock Options For Services
AdjustmentsToAdditionalPaidInCapitalGrantOfStockOptionsForServices
|
103000 | |
CY2022Q4 | us-gaap |
Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
|
47949000 | |
CY2022Q4 | us-gaap |
Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
|
47949000 | |
CY2023 | us-gaap |
Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
|
2319000 | |
CY2023 | xwel |
Adjustments To Additional Paid In Capital Grant Of Stock Options For Services
AdjustmentsToAdditionalPaidInCapitalGrantOfStockOptionsForServices
|
3000 | |
CY2023 | us-gaap |
Adjustments Related To Tax Withholding For Share Based Compensation
AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
|
22000 | |
CY2023 | us-gaap |
Noncontrolling Interest Increase From Subsidiary Equity Issuance
NoncontrollingInterestIncreaseFromSubsidiaryEquityIssuance
|
150000 | |
CY2023 | us-gaap |
Minority Interest Decrease From Distributions To Noncontrolling Interest Holders
MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders
|
120000 | |
CY2023 | us-gaap |
Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
|
-1279000 | |
CY2023 | us-gaap |
Profit Loss
ProfitLoss
|
-28029000 | |
CY2023Q4 | us-gaap |
Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
|
20971000 | |
CY2023 | us-gaap |
Profit Loss
ProfitLoss
|
-28029000 | |
CY2022 | us-gaap |
Profit Loss
ProfitLoss
|
-32629000 | |
CY2023 | us-gaap |
Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
|
2065000 | |
CY2022 | us-gaap |
Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
|
5429000 | |
CY2023 | xwel |
Impairment Of Long Lived Assets
ImpairmentOfLongLivedAssets
|
1159000 | |
CY2022 | xwel |
Impairment Of Long Lived Assets
ImpairmentOfLongLivedAssets
|
4559000 | |
CY2023 | us-gaap |
Goodwill Impairment Loss
GoodwillImpairmentLoss
|
4024000 | |
CY2023 | us-gaap |
Impairment Of Intangible Assets Finitelived
ImpairmentOfIntangibleAssetsFinitelived
|
2768000 | |
CY2022 | us-gaap |
Impairment Of Intangible Assets Finitelived
ImpairmentOfIntangibleAssetsFinitelived
|
110000 | |
CY2023 | us-gaap |
Operating Lease Impairment Loss
OperatingLeaseImpairmentLoss
|
926000 | |
CY2022 | us-gaap |
Operating Lease Impairment Loss
OperatingLeaseImpairmentLoss
|
1110000 | |
CY2023 | us-gaap |
Marketable Securities Unrealized Gain Loss
MarketableSecuritiesUnrealizedGainLoss
|
877000 | |
CY2023 | us-gaap |
Foreign Currency Transaction Loss Before Tax
ForeignCurrencyTransactionLossBeforeTax
|
738000 | |
CY2023 | us-gaap |
Gain Loss On Sale Of Other Assets
GainLossOnSaleOfOtherAssets
|
-34000 | |
CY2022 | us-gaap |
Gain Loss On Sale Of Other Assets
GainLossOnSaleOfOtherAssets
|
-834000 | |
CY2023 | us-gaap |
Gain Loss On Termination Of Lease
GainLossOnTerminationOfLease
|
821000 | |
CY2023 | us-gaap |
Finance Lease Right Of Use Asset Amortization
FinanceLeaseRightOfUseAssetAmortization
|
1481000 | |
CY2022 | us-gaap |
Finance Lease Right Of Use Asset Amortization
FinanceLeaseRightOfUseAssetAmortization
|
1844000 | |
CY2023 | us-gaap |
Issuance Of Stock And Warrants For Services Or Claims
IssuanceOfStockAndWarrantsForServicesOrClaims
|
3000 | |
CY2022 | us-gaap |
Issuance Of Stock And Warrants For Services Or Claims
IssuanceOfStockAndWarrantsForServicesOrClaims
|
103000 | |
CY2023 | us-gaap |
Share Based Compensation
ShareBasedCompensation
|
2319000 | |
CY2022 | us-gaap |
Share Based Compensation
ShareBasedCompensation
|
3770000 | |
CY2023 | us-gaap |
Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
|
-54000 | |
CY2022 | us-gaap |
Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
|
-618000 | |
CY2023 | us-gaap |
Increase Decrease In Inventories
IncreaseDecreaseInInventories
|
-261000 | |
CY2022 | us-gaap |
Increase Decrease In Inventories
IncreaseDecreaseInInventories
|
-592000 | |
CY2023 | us-gaap |
Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
|
-1191000 | |
CY2022 | us-gaap |
Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
|
1835000 | |
CY2023 | us-gaap |
Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
|
-289000 | |
CY2022 | us-gaap |
Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
|
-933000 | |
CY2023 | us-gaap |
Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
|
-512000 | |
CY2022 | us-gaap |
Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
|
457000 | |
CY2023 | xwel |
Increase Decrease In Lease Liabilities
IncreaseDecreaseInLeaseLiabilities
|
-3105000 | |
CY2022 | xwel |
Increase Decrease In Lease Liabilities
IncreaseDecreaseInLeaseLiabilities
|
-4056000 | |
CY2023 | us-gaap |
Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
|
-488000 | |
CY2022 | us-gaap |
Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
|
-3247000 | |
CY2023 | us-gaap |
Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
|
-16074000 | |
CY2022 | us-gaap |
Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
|
-24188000 | |
CY2023 | us-gaap |
Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
|
1905000 | |
CY2022 | us-gaap |
Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
|
6464000 | |
CY2022 | xwel |
Payments For Proceeds From Investments In Marketable Securities
PaymentsForProceedsFromInvestmentsInMarketableSecurities
|
23153000 | |
CY2023 | us-gaap |
Proceeds From Sale And Maturity Of Marketable Securities
ProceedsFromSaleAndMaturityOfMarketableSecurities
|
9417000 | |
CY2023 | us-gaap |
Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
|
468000 | |
CY2022 | us-gaap |
Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
|
373000 | |
CY2023 | us-gaap |
Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
|
5650000 | |
CY2022 | us-gaap |
Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
|
-34843000 | |
CY2022 | us-gaap |
Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
|
23789000 | |
CY2023 | us-gaap |
Proceeds From Minority Shareholders
ProceedsFromMinorityShareholders
|
150000 | |
CY2022 | us-gaap |
Proceeds From Minority Shareholders
ProceedsFromMinorityShareholders
|
1025000 | |
CY2023 | us-gaap |
Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
|
22000 | |
CY2022 | us-gaap |
Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
|
73000 | |
CY2022 | xwel |
Repayment Of Paycheck Protection Program
RepaymentOfPaycheckProtectionProgram
|
3584000 | |
CY2023 | us-gaap |
Payments To Minority Shareholders
PaymentsToMinorityShareholders
|
120000 | |
CY2022 | us-gaap |
Payments To Minority Shareholders
PaymentsToMinorityShareholders
|
956000 | |
CY2023 | us-gaap |
Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
|
8000 | |
CY2022 | us-gaap |
Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
|
-27377000 | |
CY2023 | us-gaap |
Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
|
-185000 | |
CY2022 | us-gaap |
Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
|
-60000 | |
CY2023 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
|
-10601000 | |
CY2022 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
|
-86468000 | |
CY2022Q4 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
19789000 | |
CY2021Q4 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
106257000 | |
CY2023Q4 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
9188000 | |
CY2022Q4 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
19789000 | |
CY2022 | us-gaap |
Interest Paid
InterestPaid
|
10000 | |
CY2023 | us-gaap |
Income Taxes Paid
IncomeTaxesPaid
|
35000 | |
CY2022 | us-gaap |
Income Taxes Paid
IncomeTaxesPaid
|
55000 | |
CY2023 | us-gaap |
Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
|
17000 | |
CY2022 | us-gaap |
Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
|
544000 | |
CY2022 | us-gaap |
Business Combination Consideration Transferred Equity Interests Issued And Issuable
BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable
|
906000 | |
CY2023 | us-gaap |
Nature Of Operations
NatureOfOperations
|
<p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;">Note 1. General</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;"><span style="font-style:italic;font-weight:bold;">Overview</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-bottom:12pt;text-align:justify;margin:0pt;">On October 25, 2022, the Company changed its name to XWELL, Inc. (“XWELL” or the “Company”) from XpresSpa Group, Inc. The Company’s common stock, par value $0.01 per share, which had previously been listed under the trading symbol “XSPA” on the Nasdaq Capital Market, now trades under the trading symbol “XWEL” since the opening of the trading market on October 25, 2022. <span style="background:#ffffff;"> In pursuance, the Company amended and restated its certificate of incorporation filed with the Delaware Secretary of State on October 24, 2022 (the “Amended and Restated Certificate”). </span> Rebranding to XWELL aligned the Company’s corporate strategy to build a pure-play health and wellness services company, both in the airport and off airport marketplaces.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-bottom:12pt;text-align:justify;background:#ffffff;margin:0pt;">In addition, prior to filing the Amended and Restated Certificate, the Company filed a Certificate of Elimination (the “Certificate of Elimination”) with respect to its Series A Convertible Preferred Stock, par value $0.01 per share, Series D Convertible Preferred Stock, par value $0.01 per share, Series E Convertible Preferred Stock, par value $0.01 per share, and Series F Convertible Preferred Stock, par value $0.01 per share (collectively, the “Eliminated Preferred Stock”) with the Delaware Secretary of State, becoming effective as of at 11:59 p.m., Eastern Time on October 24, 2022.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;background:#ffffff;margin:0pt 0pt 12pt 0pt;">The Certificate of Elimination (i) eliminated the previous designation of 6,968 shares of Series A Convertible Preferred Stock, none of which were outstanding at the time of filing, (ii) eliminated the previous designation of 500,000 shares of Series D Convertible Preferred Stock, none of which were outstanding at the time of filing, (iii) eliminated the previous designation of 2,397,060 shares of Series E Convertible Preferred Stock, none of which were outstanding at the time of filing, (iv) eliminated the previous designation of 9,000 shares of Series F Convertible Preferred Stock, none of which were outstanding at the time of filing, (v) caused such shares of Eliminated Preferred Stock to resume the status of authorized but unissued shares of preferred stock of the Company and (vi) eliminated all reference to the Eliminated Preferred Stock from the Company’s Certificate of Incorporation filed with the Secretary of State of the State of Delaware and effective prior to the effective time of the Amended and Restated Certificate.</p><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:justify;margin:0pt 0pt 12pt 0pt;"><span style="font-size:10pt;">XWELL is a global wellness company operating multiple brands and focused on bringing restorative, regenerative and reinvigorating products and services to travelers. XWELL currently has </span><span style="font-size:10pt;">four</span><span style="font-size:10pt;"> reportable operating segments: XpresSpa</span><sup style="font-size:5.62pt;line-height:100%;top:0pt;vertical-align:top;background:#ffffff;">®</sup><span style="font-size:10pt;">, XpresTest</span><sup style="font-size:5.62pt;line-height:100%;top:0pt;vertical-align:top;background:#ffffff;">®</sup><span style="font-size:10pt;">, Naples Wax Center and Treat</span><sup style="font-size:7.5pt;line-height:100%;top:0pt;vertical-align:top;background:#ffffff;">™</sup><span style="font-size:10pt;">.</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">XWELL’s subsidiary, XpresSpa Holdings, LLC (“XpresSpa”) has been a global airport retailer of spa services through its XpresSpa spa locations, offering travelers premium spa services, including massage, nail and skin care, as well as spa and travel products. Most of XpresSpa spa locations were closed between March 2020 and September 2021, largely due to the airport traffic remaining at insufficient levels to support operations at a unit level. </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">As of December 31, 2023, there were 21 domestic XpresSpa locations in total, 19 Company owned and 2 franchises. The Company also had 11 international locations operating as of December 31, 2023, including two XpresSpa locations in Dubai International Airport in the United Arab Emirates, one XpresSpa location in Zayad International Airport in Abu Dhabi UAE, three XpresSpa locations in Schiphol Amsterdam Airport in the Netherlands and five XpresSpa locations in Istanbul Airport in Turkey. </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">XWELL’s subsidiary, XpresTest, in partnership with certain COVID-19 testing partners, successfully launched its XpresCheck Wellness Centers through its XpresTest, Inc. subsidiary (“XpresTest”), which offered COVID-19 and other medical diagnostic testing services to the traveling public, as well as airline, airport and concessionaire employees, and TSA and U.S. Customs and Border Protection agents during the pandemic. During 2022 and 2023, as countries continued to relax their testing requirements resulting in rapid decline of testing volumes at the Company’s XpresCheck locations, the Company closed XpresCheck Wellness Centers. As of December 31, 2023, all XpresCheck locations are closed.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">XWELL’s subsidiary, gcg Connect, LLC, operating as HyperPointe, provides direct to business marketing support across a number of health and health-related channels. From the creation of marketing campaigns for the pharmaceutical industry, to learning management systems to website and health related content creation, HyperPointe is a complementary service provider to XWELL’s health-focused brands as well as providing the majority of services to the external community.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">For reporting purposes, the former HyperPointe segment has been consolidated into the XpresTest segment. </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">XWELL’s subsidiary Treat, Inc. (“Treat”) is a wellness brand that provides access to wellness services for travelers at on-site centers (currently located in JFK International Airport and in Salt Lake City International Airport). </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">In 2022, Treat opened a new location in Phoenix Sky Harbor International Airport but by the fourth quarter of 2022, the decision was made to close this location. The remaining Treat locations offer a full retail product offering and a suite of wellness and spa services. Travelers can purchase time blocks to use our wellness rooms to engage in interactive services like self-guided yoga, meditation and low impact weight exercises or to relax and unplug from the hectic pace of the airport and renew themselves before or after their trip.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">XWELL’s subsidiary Naples Wax Center, LLC, which was acquired on September 12, 2023, for a purchase price of $1,624 operates a group of upscale hair removal boutiques in Florida. There are currently three Naples Wax Center locations with core products and service offerings from face and body waxing to a range of skincare and cosmetic products. </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;"><span style="font-style:italic;font-weight:bold;">Liquidity and Financial Condition</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">As of December 31, 2023, the Company had approximately $8,437 of cash and cash equivalents, $14,613 in marketable securities, and total current assets of approximately $26,566. The Company’s total current liabilities balance, which includes accounts payable, deferred revenue, accrued expenses, and operating lease liabilities was approximately $9,330 as of December 31, 2023. The working capital surplus was $17,236 as of December 31, 2023, compared to a working capital surplus of $36,376 as of December 31, 2022. </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">The Company has significantly reduced operating and overhead expenses in the second half of 2022 and 2023, while it continues to focus on returning to overall profitability. </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;">The Company has taken actions to improve its overall cash position, right sizing its corporate structure and streamlining its operations, while at the same time the Company is aggressively trying to get the company to profitability which the Company believes will strengthen the Company’s stock price and put the Company in a stronger position to be able to raise capital in 2024 and beyond. The Company is aggressively pursuing strategic partnerships that the Company expects will further strengthen the long-term profitability of the business, which puts the Company in a position of strength as the Company raise more capital.</p> | |
CY2022Q4 | us-gaap |
Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
|
0.01 | |
CY2023 | us-gaap |
Number Of Operating Segments
NumberOfOperatingSegments
|
4 | |
CY2023Q4 | us-gaap |
Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
|
8437000 | |
CY2023Q4 | us-gaap |
Marketable Securities Current
MarketableSecuritiesCurrent
|
14613000 | |
CY2023Q4 | us-gaap |
Assets Current
AssetsCurrent
|
26566000 | |
CY2023Q4 | us-gaap |
Liabilities Current
LiabilitiesCurrent
|
9330000 | |
CY2023Q4 | xwel |
Working Capital
WorkingCapital
|
17236000 | |
CY2022Q4 | xwel |
Working Capital
WorkingCapital
|
36376000 | |
CY2023 | us-gaap |
Use Of Estimates
UseOfEstimates
|
<p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;"><span style="font-style:italic;font-weight:bold;">Use of estimates</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">The preparation of the accompanying consolidated financial statements in conformity with U.S. GAAP requires management to make certain estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities as of the date of the consolidated financial statements and the reported amounts of revenues and expenses for the periods presented. Actual results may differ from such estimates. Significant items subject to such estimates and assumptions include the Company’s long-lived assets, intangibles assets, the useful lives of the Company’s intangible assets, the valuation of stock-based compensation, deferred tax assets and liabilities, income tax uncertainties, and other contingencies.</p> | |
CY2023 | us-gaap |
Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
|
-738000 | |
CY2022 | us-gaap |
Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
|
-664000 | |
CY2023Q4 | us-gaap |
Cash Equivalents At Carrying Value
CashEquivalentsAtCarryingValue
|
4025000 | |
CY2022Q4 | us-gaap |
Cash Equivalents At Carrying Value
CashEquivalentsAtCarryingValue
|
1885000 | |
CY2022 | us-gaap |
Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
|
0 | |
CY2023 | us-gaap |
Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
|
0 | |
CY2023 | us-gaap |
Impairment Of Intangible Assets Finitelived
ImpairmentOfIntangibleAssetsFinitelived
|
2768000 | |
CY2022 | us-gaap |
Impairment Of Intangible Assets Finitelived
ImpairmentOfIntangibleAssetsFinitelived
|
110000 | |
CY2023 | us-gaap |
Asset Impairment Charges
AssetImpairmentCharges
|
1159000 | |
CY2022 | us-gaap |
Asset Impairment Charges
AssetImpairmentCharges
|
4559000 | |
CY2023 | us-gaap |
Operating Lease Impairment Loss
OperatingLeaseImpairmentLoss
|
926000 | |
CY2022 | us-gaap |
Operating Lease Impairment Loss
OperatingLeaseImpairmentLoss
|
1110000 | |
CY2023 | us-gaap |
Number Of Reportable Segments
NumberOfReportableSegments
|
4 | |
CY2022Q4 | us-gaap |
Unrecognized Tax Benefits
UnrecognizedTaxBenefits
|
0 | |
CY2023Q4 | us-gaap |
Unrecognized Tax Benefits
UnrecognizedTaxBenefits
|
0 | |
CY2023Q4 | xwel |
Number Of Variable Interest Entities
NumberOfVariableInterestEntities
|
0 | |
CY2023 | us-gaap |
Advertising Expense
AdvertisingExpense
|
696000 | |
CY2022 | us-gaap |
Advertising Expense
AdvertisingExpense
|
4645000 | |
CY2023 | us-gaap |
Prior Period Reclassification Adjustment Description
PriorPeriodReclassificationAdjustmentDescription
|
<p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;"><span style="font-style:italic;font-weight:bold;">Reclassification</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">Certain balances in the 2022 consolidated financial statements have been reclassified to conform to the presentation in the 2023 consolidated financial statements, primarily the separate classification and presentation of general and administrative, salaries and benefits, impairments and loss on disposal of assets. Such reclassifications did not have a material impact on the consolidated financial statements.</p> | |
CY2023 | xwel |
Net Loss Attributable To Common Shareholders
NetLossAttributableToCommonShareholders
|
-27741000 | |
CY2022 | xwel |
Net Loss Attributable To Common Shareholders
NetLossAttributableToCommonShareholders
|
-32837000 | |
CY2023 | us-gaap |
Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
|
4175220 | |
CY2022 | us-gaap |
Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
|
4682767 | |
CY2023 | us-gaap |
Earnings Per Share Basic
EarningsPerShareBasic
|
-6.64 | |
CY2022 | us-gaap |
Earnings Per Share Basic
EarningsPerShareBasic
|
-7.01 | |
CY2023 | us-gaap |
Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
|
353149 | |
CY2022 | us-gaap |
Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
|
314169 | |
CY2023Q3 | xwel |
Reverse Stock Split Multiplying Factor For Price Per Share
ReverseStockSplitMultiplyingFactorForPricePerShare
|
20 | |
CY2023Q4 | us-gaap |
Cash
Cash
|
5726000 | |
CY2022Q4 | us-gaap |
Cash
Cash
|
16344000 | |
CY2023Q4 | xwel |
Currency Other Than Us Dollars
CurrencyOtherThanUsDollars
|
2395000 | |
CY2022Q4 | xwel |
Currency Other Than Us Dollars
CurrencyOtherThanUsDollars
|
2562000 | |
CY2023Q4 | us-gaap |
Restricted Cash
RestrictedCash
|
751000 | |
CY2022Q4 | us-gaap |
Restricted Cash
RestrictedCash
|
751000 | |
CY2023Q4 | us-gaap |
Credit And Debit Card Receivables At Carrying Value
CreditAndDebitCardReceivablesAtCarryingValue
|
316000 | |
CY2022Q4 | us-gaap |
Credit And Debit Card Receivables At Carrying Value
CreditAndDebitCardReceivablesAtCarryingValue
|
132000 | |
CY2023Q4 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
9188000 | |
CY2022Q4 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
19789000 | |
CY2023Q4 | us-gaap |
Time Deposits At Or Above Fdic Insurance Limit
TimeDepositsAtOrAboveFDICInsuranceLimit
|
4195000 | |
CY2022Q4 | us-gaap |
Time Deposits At Or Above Fdic Insurance Limit
TimeDepositsAtOrAboveFDICInsuranceLimit
|
16069000 | |
CY2023Q4 | xwel |
Cash Held In Overseas Accounts
CashHeldInOverseasAccounts
|
2395000 | |
CY2022Q4 | xwel |
Cash Held In Overseas Accounts
CashHeldInOverseasAccounts
|
2562000 | |
CY2023Q4 | us-gaap |
Prepaid Expense Current
PrepaidExpenseCurrent
|
894000 | |
CY2022Q4 | us-gaap |
Prepaid Expense Current
PrepaidExpenseCurrent
|
1074000 | |
CY2023Q4 | us-gaap |
Other Assets Miscellaneous Current
OtherAssetsMiscellaneousCurrent
|
55000 | |
CY2022Q4 | us-gaap |
Other Assets Miscellaneous Current
OtherAssetsMiscellaneousCurrent
|
48000 | |
CY2023Q4 | us-gaap |
Other Assets Current
OtherAssetsCurrent
|
949000 | |
CY2022Q4 | us-gaap |
Other Assets Current
OtherAssetsCurrent
|
1122000 | |
CY2023Q4 | us-gaap |
Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
|
7349000 | |
CY2022Q4 | us-gaap |
Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
|
10666000 | |
CY2023Q4 | us-gaap |
Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
|
4895000 | |
CY2022Q4 | us-gaap |
Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
|
7000000 | |
CY2023Q4 | us-gaap |
Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
|
2454000 | |
CY2022Q4 | us-gaap |
Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
|
3666000 | |
CY2023 | us-gaap |
Asset Impairment Charges
AssetImpairmentCharges
|
1159000 | |
CY2022 | us-gaap |
Asset Impairment Charges
AssetImpairmentCharges
|
4559000 | |
CY2023 | us-gaap |
Depreciation
Depreciation
|
825000 | |
CY2022 | us-gaap |
Depreciation
Depreciation
|
3663000 | |
CY2023Q4 | us-gaap |
Finite Lived Intangible Assets Amortization Expense Year Five
FiniteLivedIntangibleAssetsAmortizationExpenseYearFive
|
122000 | |
CY2023Q4 | us-gaap |
Finite Lived Intangible Assets Amortization Expense After Year Five
FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive
|
254000 | |
CY2022 | xwel |
Operating Lease Minimum Annual Rental Payments
OperatingLeaseMinimumAnnualRentalPayments
|
928000 | |
CY2023 | us-gaap |
Variable Lease Payment
VariableLeasePayment
|
1326000 | |
CY2023Q4 | us-gaap |
Equity Securities Without Readily Determinable Fair Value Amount
EquitySecuritiesWithoutReadilyDeterminableFairValueAmount
|
50000 | |
CY2022Q4 | us-gaap |
Equity Securities Without Readily Determinable Fair Value Amount
EquitySecuritiesWithoutReadilyDeterminableFairValueAmount
|
104000 | |
CY2023Q4 | us-gaap |
Leveraged Lease Investment
LeveragedLeaseInvestment
|
1556000 | |
CY2022Q4 | us-gaap |
Leveraged Lease Investment
LeveragedLeaseInvestment
|
1973000 | |
CY2023Q4 | us-gaap |
Other Assets Miscellaneous Noncurrent
OtherAssetsMiscellaneousNoncurrent
|
236000 | |
CY2022Q4 | us-gaap |
Other Assets Miscellaneous Noncurrent
OtherAssetsMiscellaneousNoncurrent
|
292000 | |
CY2023Q4 | us-gaap |
Other Assets Noncurrent
OtherAssetsNoncurrent
|
1842000 | |
CY2022Q4 | us-gaap |
Other Assets Noncurrent
OtherAssetsNoncurrent
|
2369000 | |
CY2023Q4 | us-gaap |
Leveraged Lease Investment
LeveragedLeaseInvestment
|
1556000 | |
CY2022Q4 | us-gaap |
Leveraged Lease Investment
LeveragedLeaseInvestment
|
1973000 | |
CY2023Q4 | us-gaap |
Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
|
3840000 | |
CY2023Q4 | us-gaap |
Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
|
2487000 | |
CY2023Q4 | us-gaap |
Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
|
1353000 | |
CY2022Q4 | us-gaap |
Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
|
6352000 | |
CY2022Q4 | us-gaap |
Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
|
2344000 | |
CY2022Q4 | us-gaap |
Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
|
4008000 | |
CY2023 | xwel |
Amortization And Impairment Of Intangible Assets
AmortizationAndImpairmentOfIntangibleAssets
|
1240000 | |
CY2022 | xwel |
Amortization And Impairment Of Intangible Assets
AmortizationAndImpairmentOfIntangibleAssets
|
1766000 | |
CY2023Q4 | us-gaap |
Finite Lived Intangible Assets Amortization Expense Next Twelve Months
FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths
|
316000 | |
CY2023Q4 | us-gaap |
Finite Lived Intangible Assets Amortization Expense Year Two
FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
|
310000 | |
CY2023Q4 | us-gaap |
Finite Lived Intangible Assets Amortization Expense Year Three
FiniteLivedIntangibleAssetsAmortizationExpenseYearThree
|
229000 | |
CY2023Q4 | us-gaap |
Finite Lived Intangible Assets Amortization Expense Year Four
FiniteLivedIntangibleAssetsAmortizationExpenseYearFour
|
122000 | |
CY2023Q4 | us-gaap |
Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
|
1353000 | |
CY2023 | us-gaap |
Operating Lease Payments
OperatingLeasePayments
|
3483000 | |
CY2022 | us-gaap |
Operating Lease Payments
OperatingLeasePayments
|
4092000 | |
CY2023 | xwel |
Right Of Use Asset Obtained In Exchange For New And Modified Operating Lease Liability
RightOfUseAssetObtainedInExchangeForNewAndModifiedOperatingLeaseLiability
|
174000 | |
CY2022 | xwel |
Right Of Use Asset Obtained In Exchange For New And Modified Operating Lease Liability
RightOfUseAssetObtainedInExchangeForNewAndModifiedOperatingLeaseLiability
|
6891000 | |
CY2023Q4 | us-gaap |
Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
|
3105000 | |
CY2023Q4 | us-gaap |
Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
|
2714000 | |
CY2023Q4 | us-gaap |
Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
|
1628000 | |
CY2023Q4 | us-gaap |
Lessee Operating Lease Liability Payments Due Year Four
LesseeOperatingLeaseLiabilityPaymentsDueYearFour
|
1505000 | |
CY2023Q4 | us-gaap |
Lessee Operating Lease Liability Payments Due Year Five
LesseeOperatingLeaseLiabilityPaymentsDueYearFive
|
1125000 | |
CY2023Q4 | us-gaap |
Lessee Operating Lease Liability Payments Due After Year Five
LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive
|
3313000 | |
CY2023Q4 | us-gaap |
Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
|
13390000 | |
CY2023Q4 | us-gaap |
Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
|
2296000 | |
CY2023Q4 | us-gaap |
Operating Lease Liability
OperatingLeaseLiability
|
11094000 | |
CY2023Q4 | us-gaap |
Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
|
P5Y11M8D | |
CY2023Q4 | us-gaap |
Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
|
0.0725 | |
CY2023 | xwel |
Operating Lease Minimum Annual Rental Payments
OperatingLeaseMinimumAnnualRentalPayments
|
2018000 | |
CY2022 | us-gaap |
Variable Lease Payment
VariableLeasePayment
|
1392000 | |
CY2023 | us-gaap |
Operating Lease Expense
OperatingLeaseExpense
|
3824000 | |
CY2022 | us-gaap |
Operating Lease Expense
OperatingLeaseExpense
|
3917000 | |
CY2023 | us-gaap |
Operating Lease Impairment Loss
OperatingLeaseImpairmentLoss
|
926000 | |
CY2022 | us-gaap |
Operating Lease Impairment Loss
OperatingLeaseImpairmentLoss
|
1110000 | |
CY2023Q3 | xwel |
Reverse Stock Split Multiplying Factor For Price Per Share
ReverseStockSplitMultiplyingFactorForPricePerShare
|
20 | |
CY2022Q3 | xwel |
Threshold Value Of Share Repurchases
ThresholdValueOfShareRepurchases
|
1000000 | |
CY2023Q4 | xwel |
Number Of Equal Quarterly Vesting Installment
NumberOfEqualQuarterlyVestingInstallment
|
4 | |
CY2020Q3 | xwel |
Number Of Equal Quarterly Vesting Installment
NumberOfEqualQuarterlyVestingInstallment
|
4 | |
CY2023 | us-gaap |
Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
|
2319000 | |
CY2022 | us-gaap |
Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
|
3770000 | |
CY2022Q4 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
|
241501 | |
CY2022Q4 | us-gaap |
Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Weighted Average Grant Date Fair Value
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue
|
40.00 | |
CY2023 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
|
148069 | |
CY2023 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
|
7.88 | |
CY2023 | us-gaap |
Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
|
0 | |
CY2023 | us-gaap |
Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested Weighted Average Grant Date Fair Value
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue
|
0 | |
CY2023 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
|
16699 | |
CY2023 | us-gaap |
Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Options Forfeited Weighted Average Grant Date Fair Value
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedWeightedAverageGrantDateFairValue
|
24.08 | |
CY2023 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod
|
31666 | |
CY2023 | xwel |
Share Based Compensation Arrangement By Share Based Payment Award Vested Options Expired Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardVestedOptionsExpiredWeightedAverageGrantDateFairValue
|
38.69 | |
CY2023Q4 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
|
341205 | |
CY2023Q4 | us-gaap |
Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Weighted Average Grant Date Fair Value
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue
|
26.85 | |
CY2023Q4 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
|
244271 | |
CY2023 | xwel |
Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableInPeriodWeightedAverageGrantDateFairValue
|
26.65 | |
CY2021Q4 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
|
141344 | |
CY2021Q4 | us-gaap |
Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Weighted Average Grant Date Fair Value
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue
|
51.40 | |
CY2022 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
|
117517 | |
CY2022 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
|
29.20 | |
CY2022 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
|
12252 | |
CY2022 | us-gaap |
Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Options Forfeited Weighted Average Grant Date Fair Value
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedWeightedAverageGrantDateFairValue
|
31.00 | |
CY2022 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod
|
5108 | |
CY2022 | xwel |
Share Based Compensation Arrangement By Share Based Payment Award Vested Options Expired Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardVestedOptionsExpiredWeightedAverageGrantDateFairValue
|
121.0 | |
CY2022Q4 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
|
241501 | |
CY2022Q4 | us-gaap |
Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Weighted Average Grant Date Fair Value
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue
|
40.00 | |
CY2022Q4 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
|
103063 | |
CY2022 | xwel |
Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableInPeriodWeightedAverageGrantDateFairValue
|
51.20 | |
CY2023 | us-gaap |
Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
|
P7Y8M15D | |
CY2022 | us-gaap |
Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
|
P7Y9M29D | |
CY2023Q4 | xwel |
Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding And Vested Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingAndVestedIntrinsicValue
|
0 | |
CY2022Q4 | xwel |
Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding And Vested Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingAndVestedIntrinsicValue
|
0 | |
CY2023 | us-gaap |
Number Of Operating Segments
NumberOfOperatingSegments
|
4 | |
CY2023 | us-gaap |
Number Of Reportable Segments
NumberOfReportableSegments
|
4 | |
CY2023Q4 | xwel |
Number Of Locations Operated
NumberOfLocationsOperated
|
2 | |
CY2023 | us-gaap |
Revenues
Revenues
|
30109000 | |
CY2022 | us-gaap |
Revenues
Revenues
|
55939000 | |
CY2023Q4 | xwel |
Long Lived Assets
LongLivedAssets
|
10838000 | |
CY2022Q4 | xwel |
Long Lived Assets
LongLivedAssets
|
18794000 | |
CY2023 | us-gaap |
Revenues
Revenues
|
30109000 | |
CY2022 | us-gaap |
Revenues
Revenues
|
55939000 | |
CY2023 | us-gaap |
Operating Income Loss
OperatingIncomeLoss
|
-28206000 | |
CY2022 | us-gaap |
Operating Income Loss
OperatingIncomeLoss
|
-31163000 | |
CY2023 | us-gaap |
Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
|
2065000 | |
CY2022 | us-gaap |
Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
|
5429000 | |
CY2023Q4 | xwel |
Property Plant Equipment Capital Expenditure
PropertyPlantEquipmentCapitalExpenditure
|
1847000 | |
CY2022Q4 | xwel |
Property Plant Equipment Capital Expenditure
PropertyPlantEquipmentCapitalExpenditure
|
6293000 | |
CY2023Q4 | xwel |
Long Lived Assets
LongLivedAssets
|
10838000 | |
CY2022Q4 | xwel |
Long Lived Assets
LongLivedAssets
|
18794000 | |
CY2023Q4 | us-gaap |
Assets
Assets
|
38993000 | |
CY2022Q4 | us-gaap |
Assets
Assets
|
70426000 | |
CY2023Q4 | us-gaap |
Loss Contingency Accrual Carrying Value Current
LossContingencyAccrualCarryingValueCurrent
|
449000 | |
CY2022Q4 | us-gaap |
Loss Contingency Accrual Carrying Value Current
LossContingencyAccrualCarryingValueCurrent
|
963000 | |
CY2023Q4 | us-gaap |
Workers Compensation Liability Current
WorkersCompensationLiabilityCurrent
|
2098000 | |
CY2022Q4 | us-gaap |
Workers Compensation Liability Current
WorkersCompensationLiabilityCurrent
|
2008000 | |
CY2023Q4 | us-gaap |
Taxes Payable Current
TaxesPayableCurrent
|
501000 | |
CY2022Q4 | us-gaap |
Taxes Payable Current
TaxesPayableCurrent
|
573000 | |
CY2023Q4 | us-gaap |
Accounts Payable Other Current
AccountsPayableOtherCurrent
|
8000 | |
CY2022Q4 | us-gaap |
Accounts Payable Other Current
AccountsPayableOtherCurrent
|
160000 | |
CY2023Q4 | us-gaap |
Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
|
913000 | |
CY2022Q4 | us-gaap |
Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
|
754000 | |
CY2023Q4 | xwel |
Accrued Liability For Unredeemed Gift Cards
AccruedLiabilityForUnredeemedGiftCards
|
509000 | |
CY2022Q4 | xwel |
Accrued Liability For Unredeemed Gift Cards
AccruedLiabilityForUnredeemedGiftCards
|
496000 | |
CY2023Q4 | xwel |
Credit Card Processing Fees
CreditCardProcessingFees
|
8000 | |
CY2022Q4 | xwel |
Credit Card Processing Fees
CreditCardProcessingFees
|
33000 | |
CY2023Q4 | us-gaap |
Accounts Payable And Other Accrued Liabilities Current
AccountsPayableAndOtherAccruedLiabilitiesCurrent
|
482000 | |
CY2022Q4 | us-gaap |
Accounts Payable And Other Accrued Liabilities Current
AccountsPayableAndOtherAccruedLiabilitiesCurrent
|
732000 | |
CY2023Q4 | us-gaap |
Accrued Liabilities And Other Liabilities
AccruedLiabilitiesAndOtherLiabilities
|
4968000 | |
CY2022Q4 | us-gaap |
Accrued Liabilities And Other Liabilities
AccruedLiabilitiesAndOtherLiabilities
|
5719000 | |
CY2023 | us-gaap |
Income Loss From Continuing Operations Before Income Taxes Domestic
IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
|
-27573000 | |
CY2022 | us-gaap |
Income Loss From Continuing Operations Before Income Taxes Domestic
IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
|
-32445000 | |
CY2023 | us-gaap |
Income Loss From Continuing Operations Before Income Taxes Foreign
IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign
|
-421000 | |
CY2022 | us-gaap |
Income Loss From Continuing Operations Before Income Taxes Foreign
IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign
|
-129000 | |
CY2023 | us-gaap |
Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
|
-27994000 | |
CY2022 | us-gaap |
Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
|
-32574000 | |
CY2023 | us-gaap |
Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
|
0 | |
CY2022 | us-gaap |
Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
|
0 | |
CY2023 | us-gaap |
Current State And Local Tax Expense Benefit
CurrentStateAndLocalTaxExpenseBenefit
|
15000 | |
CY2022 | us-gaap |
Current State And Local Tax Expense Benefit
CurrentStateAndLocalTaxExpenseBenefit
|
41000 | |
CY2023 | us-gaap |
Current Foreign Tax Expense Benefit
CurrentForeignTaxExpenseBenefit
|
20000 | |
CY2022 | us-gaap |
Current Foreign Tax Expense Benefit
CurrentForeignTaxExpenseBenefit
|
14000 | |
CY2023 | us-gaap |
Deferred Federal Income Tax Expense Benefit
DeferredFederalIncomeTaxExpenseBenefit
|
0 | |
CY2022 | us-gaap |
Deferred Federal Income Tax Expense Benefit
DeferredFederalIncomeTaxExpenseBenefit
|
0 | |
CY2023 | us-gaap |
Deferred Federal State And Local Tax Expense Benefit
DeferredFederalStateAndLocalTaxExpenseBenefit
|
35000 | |
CY2022 | us-gaap |
Deferred Federal State And Local Tax Expense Benefit
DeferredFederalStateAndLocalTaxExpenseBenefit
|
55000 | |
CY2023 | us-gaap |
Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
|
-27994000 | |
CY2022 | us-gaap |
Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
|
-32574000 | |
CY2023 | us-gaap |
Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
|
0.21 | |
CY2022 | us-gaap |
Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
|
0.21 | |
CY2023 | xwel |
Effective Income Tax Rate Reconciliation Tax Credits And Adjustments Other Amount
EffectiveIncomeTaxRateReconciliationTaxCreditsAndAdjustmentsOtherAmount
|
5879000 | |
CY2022 | xwel |
Effective Income Tax Rate Reconciliation Tax Credits And Adjustments Other Amount
EffectiveIncomeTaxRateReconciliationTaxCreditsAndAdjustmentsOtherAmount
|
6841000 | |
CY2023 | us-gaap |
Income Tax Reconciliation State And Local Income Taxes
IncomeTaxReconciliationStateAndLocalIncomeTaxes
|
-1027000 | |
CY2022 | us-gaap |
Income Tax Reconciliation State And Local Income Taxes
IncomeTaxReconciliationStateAndLocalIncomeTaxes
|
706000 | |
CY2023 | us-gaap |
Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance
IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
|
9166000 | |
CY2022 | us-gaap |
Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance
IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
|
7015000 | |
CY2022 | xwel |
Effective Income Tax Reconciliation Adjustment Joint Venture Basis
EffectiveIncomeTaxReconciliationAdjustmentJointVentureBasis
|
339000 | |
CY2023 | us-gaap |
Income Tax Reconciliation Nondeductible Expense
IncomeTaxReconciliationNondeductibleExpense
|
212000 | |
CY2022 | us-gaap |
Income Tax Reconciliation Nondeductible Expense
IncomeTaxReconciliationNondeductibleExpense
|
341000 | |
CY2023 | us-gaap |
Income Tax Reconciliation Other Adjustments
IncomeTaxReconciliationOtherAdjustments
|
2000 | |
CY2023 | xwel |
Effective Income Tax Rate Reconciliation Nondeductible Expense Return To Provision Adjustment Amount
EffectiveIncomeTaxRateReconciliationNondeductibleExpenseReturnToProvisionAdjustmentAmount
|
-1860000 | |
CY2022 | xwel |
Effective Income Tax Rate Reconciliation Nondeductible Expense Return To Provision Adjustment Amount
EffectiveIncomeTaxRateReconciliationNondeductibleExpenseReturnToProvisionAdjustmentAmount
|
-94000 | |
CY2023 | us-gaap |
Income Tax Reconciliation Foreign Income Tax Rate Differential
IncomeTaxReconciliationForeignIncomeTaxRateDifferential
|
-14000 | |
CY2023 | xwel |
Income Tax Reconciliation Change In State Deferred Rate
IncomeTaxReconciliationChangeInStateDeferredRate
|
-87000 | |
CY2022 | xwel |
Income Tax Reconciliation Change In State Deferred Rate
IncomeTaxReconciliationChangeInStateDeferredRate
|
-570000 | |
CY2023 | xwel |
Income Tax Reconciliation Asset Impairment Adjustment
IncomeTaxReconciliationAssetImpairmentAdjustment
|
-730000 | |
CY2022 | xwel |
Income Tax Reconciliation Asset Impairment Adjustment
IncomeTaxReconciliationAssetImpairmentAdjustment
|
-810000 | |
CY2023 | us-gaap |
Income Tax Reconciliation Other Reconciling Items
IncomeTaxReconciliationOtherReconcilingItems
|
252000 | |
CY2022 | us-gaap |
Income Tax Reconciliation Other Reconciling Items
IncomeTaxReconciliationOtherReconcilingItems
|
-31000 | |
CY2023 | us-gaap |
Income Tax Expense Benefit
IncomeTaxExpenseBenefit
|
35000 | |
CY2022 | us-gaap |
Income Tax Expense Benefit
IncomeTaxExpenseBenefit
|
55000 | |
CY2023Q3 | us-gaap |
Assets
Assets
|
42937000 | |
CY2023Q3 | us-gaap |
Accounts Payable Current
AccountsPayableCurrent
|
1511000 | |
CY2023Q3 | us-gaap |
Accrued Liabilities And Other Liabilities
AccruedLiabilitiesAndOtherLiabilities
|
4198000 | |
CY2023Q3 | us-gaap |
Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
|
2375000 | |
CY2023Q3 | us-gaap |
Deferred Revenue
DeferredRevenue
|
73000 | |
CY2023Q3 | us-gaap |
Liabilities Current
LiabilitiesCurrent
|
8157000 | |
CY2023Q3 | us-gaap |
Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
|
9123000 | |
CY2023Q3 | us-gaap |
Liabilities
Liabilities
|
17280000 | |
CY2023Q4 | us-gaap |
Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
|
60263000 | |
CY2022Q4 | us-gaap |
Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
|
51932000 | |
CY2023Q4 | us-gaap |
Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost
|
1532000 | |
CY2022Q4 | us-gaap |
Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost
|
1029000 | |
CY2023Q4 | us-gaap |
Deferred Tax Assets Goodwill And Intangible Assets
DeferredTaxAssetsGoodwillAndIntangibleAssets
|
7629000 | |
CY2022Q4 | us-gaap |
Deferred Tax Assets Goodwill And Intangible Assets
DeferredTaxAssetsGoodwillAndIntangibleAssets
|
7298000 | |
CY2023Q4 | us-gaap |
Deferred Tax Assets Tax Deferred Expense Compensation And Benefits
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits
|
69424000 | |
CY2022Q4 | us-gaap |
Deferred Tax Assets Tax Deferred Expense Compensation And Benefits
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits
|
60259000 | |
CY2023Q4 | us-gaap |
Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
|
69424000 | |
CY2022Q4 | us-gaap |
Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
|
60259000 | |
CY2023Q4 | us-gaap |
Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
|
69424000 | |
CY2021Q4 | us-gaap |
Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
|
53298000 | |
CY2022Q4 | xwel |
Deferred Tax Assets Return To Provision Trueup
DeferredTaxAssetsReturnToProvisionTrueup
|
-97000 | |
CY2022Q4 | us-gaap |
Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
|
60259000 | |
CY2023Q4 | xwel |
Deferred Tax Assets Return To Provision Trueup
DeferredTaxAssetsReturnToProvisionTrueup
|
-1866000 | |
CY2023Q4 | us-gaap |
Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
|
69424000 | |
CY2023Q4 | us-gaap |
Operating Loss Carryforwards
OperatingLossCarryforwards
|
150926000 | |
CY2023 | xwel |
Net Operating Loss Expiration
NetOperatingLossExpiration
|
P20Y | |
CY2023Q4 | xwel |
Operating Loss Carry Forwards Without Limitation
OperatingLossCarryForwardsWithoutLimitation
|
97968000 | |
CY2023Q3 | us-gaap |
Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
|
4827000 | |
CY2023Q3 | us-gaap |
Marketable Securities Current
MarketableSecuritiesCurrent
|
21311000 | |
CY2023Q3 | us-gaap |
Accounts Receivable Net Current
AccountsReceivableNetCurrent
|
1193000 | |
CY2023Q3 | us-gaap |
Inventory Net
InventoryNet
|
968000 | |
CY2023Q3 | us-gaap |
Other Assets Current
OtherAssetsCurrent
|
1663000 | |
CY2023Q3 | us-gaap |
Assets Current
AssetsCurrent
|
29962000 | |
CY2023Q3 | us-gaap |
Restricted Cash And Cash Equivalents Noncurrent
RestrictedCashAndCashEquivalentsNoncurrent
|
751000 | |
CY2023Q3 | us-gaap |
Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
|
2705000 | |
CY2023Q3 | us-gaap |
Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
|
2174000 | |
CY2023Q3 | us-gaap |
Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
|
5558000 | |
CY2023Q3 | us-gaap |
Other Assets Noncurrent
OtherAssetsNoncurrent
|
1787000 | |
us-gaap |
Debt And Equity Securities Realized Gain Loss
DebtAndEquitySecuritiesRealizedGainLoss
|
703000 | ||
CY2023Q3 | us-gaap |
Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
|
0.01 | |
CY2022Q4 | us-gaap |
Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
|
0.01 | |
CY2023Q3 | us-gaap |
Common Stock Shares Authorized
CommonStockSharesAuthorized
|
150000000 | |
CY2022Q4 | us-gaap |
Common Stock Shares Authorized
CommonStockSharesAuthorized
|
150000000 | |
CY2023Q3 | us-gaap |
Common Stock Shares Issued
CommonStockSharesIssued
|
4174381 | |
CY2022Q4 | us-gaap |
Common Stock Shares Outstanding
CommonStockSharesOutstanding
|
4161613 | |
CY2023Q3 | us-gaap |
Common Stock Value
CommonStockValue
|
42000 | |
CY2023Q3 | us-gaap |
Additional Paid In Capital
AdditionalPaidInCapital
|
470270000 | |
CY2023Q3 | us-gaap |
Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
|
-450882000 | |
CY2023Q3 | us-gaap |
Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
|
-1642000 | |
CY2023Q3 | us-gaap |
Stockholders Equity
StockholdersEquity
|
17788000 | |
CY2023Q3 | us-gaap |
Minority Interest
MinorityInterest
|
7869000 | |
CY2023Q3 | us-gaap |
Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
|
25657000 | |
CY2023Q3 | us-gaap |
Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
|
42937000 | |
CY2023Q3 | us-gaap |
Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
|
7468000 | |
us-gaap |
Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
|
22706000 | ||
CY2023Q3 | us-gaap |
Cost Direct Labor
CostDirectLabor
|
4462000 | |
us-gaap |
Cost Direct Labor
CostDirectLabor
|
13609000 | ||
CY2023Q3 | xwel |
Cost Of Occupancy
CostOfOccupancy
|
1063000 | |
xwel |
Cost Of Occupancy
CostOfOccupancy
|
3237000 | ||
CY2023Q3 | xwel |
Products And Other Operating Costs
ProductsAndOtherOperatingCosts
|
852000 | |
xwel |
Products And Other Operating Costs
ProductsAndOtherOperatingCosts
|
3057000 | ||
CY2023Q3 | us-gaap |
Cost Of Revenue
CostOfRevenue
|
6377000 | |
us-gaap |
Cost Of Revenue
CostOfRevenue
|
19903000 | ||
CY2023Q3 | us-gaap |
Gross Profit
GrossProfit
|
1091000 | |
us-gaap |
Gross Profit
GrossProfit
|
2803000 | ||
CY2023Q3 | us-gaap |
Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
|
590000 | |
us-gaap |
Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
|
1770000 | ||
CY2023Q3 | us-gaap |
Impairment Of Long Lived Assets Held For Use
ImpairmentOfLongLivedAssetsHeldForUse
|
-7878000 | |
us-gaap |
Impairment Of Long Lived Assets Held For Use
ImpairmentOfLongLivedAssetsHeldForUse
|
-7878000 | ||
CY2023Q3 | us-gaap |
Operating Lease Impairment Loss
OperatingLeaseImpairmentLoss
|
517000 | |
us-gaap |
Operating Lease Impairment Loss
OperatingLeaseImpairmentLoss
|
517000 | ||
CY2023Q3 | us-gaap |
Gain Loss On Disposition Of Assets1
GainLossOnDispositionOfAssets1
|
-16000 | |
us-gaap |
Gain Loss On Disposition Of Assets1
GainLossOnDispositionOfAssets1
|
-34000 | ||
CY2023Q3 | us-gaap |
Marketing And Advertising Expense
MarketingAndAdvertisingExpense
|
313000 | |
us-gaap |
Marketing And Advertising Expense
MarketingAndAdvertisingExpense
|
628000 | ||
CY2023Q3 | us-gaap |
Information Technology And Data Processing
InformationTechnologyAndDataProcessing
|
273000 | |
us-gaap |
Information Technology And Data Processing
InformationTechnologyAndDataProcessing
|
1186000 | ||
CY2023Q3 | us-gaap |
Other General And Administrative Expense
OtherGeneralAndAdministrativeExpense
|
3593000 | |
us-gaap |
Other General And Administrative Expense
OtherGeneralAndAdministrativeExpense
|
13891000 | ||
CY2023Q3 | us-gaap |
Costs And Expenses
CostsAndExpenses
|
13180000 | |
us-gaap |
Costs And Expenses
CostsAndExpenses
|
25904000 | ||
CY2023Q3 | us-gaap |
Operating Income Loss
OperatingIncomeLoss
|
-12089000 | |
us-gaap |
Operating Income Loss
OperatingIncomeLoss
|
-23101000 | ||
CY2023Q3 | us-gaap |
Interest Income Expense Net
InterestIncomeExpenseNet
|
105000 | |
us-gaap |
Interest Income Expense Net
InterestIncomeExpenseNet
|
334000 | ||
CY2023Q3 | us-gaap |
Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
|
366000 | |
us-gaap |
Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
|
-690000 | ||
CY2023Q3 | us-gaap |
Debt And Equity Securities Realized Gain Loss
DebtAndEquitySecuritiesRealizedGainLoss
|
225000 | |
CY2023Q3 | us-gaap |
Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
|
-198000 | |
us-gaap |
Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
|
-345000 | ||
CY2023Q3 | us-gaap |
Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
|
-11591000 | |
us-gaap |
Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
|
-23099000 | ||
CY2023Q3 | us-gaap |
Profit Loss
ProfitLoss
|
-11591000 | |
us-gaap |
Profit Loss
ProfitLoss
|
-23099000 | ||
CY2023Q3 | us-gaap |
Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
|
-60000 | |
us-gaap |
Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
|
-329000 | ||
CY2023Q3 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-11531000 | |
us-gaap |
Net Income Loss
NetIncomeLoss
|
-22770000 | ||
CY2023Q3 | us-gaap |
Profit Loss
ProfitLoss
|
-11591000 | |
us-gaap |
Profit Loss
ProfitLoss
|
-23099000 | ||
CY2023Q3 | us-gaap |
Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
|
-514000 | |
us-gaap |
Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
|
-1108000 | ||
CY2023Q3 | xwel |
Comprehensive Income Loss Net Of Tax Attributable To Parent Continuing Operations
ComprehensiveIncomeLossNetOfTaxAttributableToParentContinuingOperations
|
-12105000 | |
xwel |
Comprehensive Income Loss Net Of Tax Attributable To Parent Continuing Operations
ComprehensiveIncomeLossNetOfTaxAttributableToParentContinuingOperations
|
-24207000 | ||
CY2023Q3 | us-gaap |
Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
|
-12105000 | |
us-gaap |
Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
|
-24207000 | ||
CY2023Q3 | us-gaap |
Earnings Per Share Basic
EarningsPerShareBasic
|
-2.76 | |
us-gaap |
Earnings Per Share Basic
EarningsPerShareBasic
|
-5.46 | ||
CY2023Q3 | us-gaap |
Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
|
4173894 | |
us-gaap |
Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
|
4170629 | ||
CY2023Q3 | us-gaap |
Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
|
4173894 | |
us-gaap |
Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
|
4170629 | ||
CY2023Q3 | us-gaap |
Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
|
25657000 | |
us-gaap |
Profit Loss
ProfitLoss
|
-23099000 | ||
us-gaap |
Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
|
1770000 | ||
xwel |
Impairment Of Long Lived Assets
ImpairmentOfLongLivedAssets
|
8395000 | ||
us-gaap |
Foreign Currency Transaction Loss Before Tax
ForeignCurrencyTransactionLossBeforeTax
|
690000 | ||
us-gaap |
Gain Loss On Sale Of Other Assets
GainLossOnSaleOfOtherAssets
|
-34000 | ||
us-gaap |
Gain Loss On Termination Of Lease
GainLossOnTerminationOfLease
|
821000 | ||
us-gaap |
Marketable Securities Unrealized Gain Loss
MarketableSecuritiesUnrealizedGainLoss
|
668000 | ||
us-gaap |
Finance Lease Right Of Use Asset Amortization
FinanceLeaseRightOfUseAssetAmortization
|
1163000 | ||
us-gaap |
Share Based Compensation
ShareBasedCompensation
|
1832000 | ||
us-gaap |
Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
|
-53000 | ||
us-gaap |
Increase Decrease In Inventories
IncreaseDecreaseInInventories
|
-192000 | ||
us-gaap |
Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
|
-1665000 | ||
us-gaap |
Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
|
336000 | ||
us-gaap |
Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
|
-266000 | ||
xwel |
Increase Decrease In Lease Liabilities
IncreaseDecreaseInLeaseLiabilities
|
-3226000 | ||
us-gaap |
Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
|
-251000 | ||
us-gaap |
Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
|
-12873000 | ||
us-gaap |
Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
|
1639000 | ||
xwel |
Payments For Proceeds From Investments In Marketable Securities
PaymentsForProceedsFromInvestmentsInMarketableSecurities
|
1991000 | ||
us-gaap |
Proceeds From Sale And Maturity Of Marketable Securities
ProceedsFromSaleAndMaturityOfMarketableSecurities
|
4500000 | ||
us-gaap |
Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
|
468000 | ||
us-gaap |
Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
|
-1172000 | ||
us-gaap |
Proceeds From Minority Shareholders
ProceedsFromMinorityShareholders
|
150000 | ||
us-gaap |
Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
|
22000 | ||
us-gaap |
Payments To Minority Shareholders
PaymentsToMinorityShareholders
|
120000 | ||
us-gaap |
Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
|
8000 | ||
us-gaap |
Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
|
-174000 | ||
us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
|
-14211000 | ||
CY2022Q4 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
19789000 | |
CY2023Q3 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
5578000 | |
us-gaap |
Income Taxes Paid Net
IncomeTaxesPaidNet
|
142000 | ||
us-gaap |
Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
|
197000 |